Gunman in Custody Following Fatal Shooting of United Healthcare CEO
December 9, 2024 - 19:40
Authorities have apprehended a person of interest in connection with the shocking shooting of Brian Thompson, the CEO of United Healthcare, in Midtown Manhattan. The incident, described as a "brazen" attack, has sent ripples of concern throughout the community and the corporate world.
The New York Police Department had been actively searching for the gunman since the tragic event unfolded. Witnesses reported hearing multiple gunshots, which led to a swift response from law enforcement. Emergency services rushed Thompson to a nearby hospital, but he was pronounced dead shortly after arrival.
This incident has raised questions about safety in the bustling area of Midtown, known for its high foot traffic and numerous businesses. Community leaders and local officials are calling for increased security measures to ensure the safety of residents and visitors alike. As the investigation unfolds, police are working diligently to piece together the events leading up to the shooting and understand the motive behind this violent act.
MORE NEWS
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...
July 20, 2026 - 11:31
Seven peptides are under review by an FDA panel this week. Here’s everything we knowA federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...